---
created: 2025-04-13
updated: 2025-04-13T10:52
id: b/j}o1H=k)
specialty: immuno
specialty_id: 95
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::12-immunology::03-pharm::02-immunosuppressive-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::01-immunosuppressants
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::01-immunosuppressants::sirolimus/rapamycin
  - "source/ak-step1-v11:": 
  - theme/ome::07-immunology::16-immunosuppression
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology::16-immunosuppression
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::01-immunology::03-sirolimus
  - "source/ak-step1-v11:": 
  - theme/pixorize::01-immunology::05-cytokines::03-il-2
  - "source/ak-step1-v11:": 
  - theme/pixorize::01-immunology::09-immunosuppressants::03-sirolimus-(rapamycin)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::immunology-&-biochemistry-pharmacology::immuno-suppressives::transplant-rejection-prophylaxis
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::11000-11999::11786
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
Sirolimus (rapamycin) is an immunosuppressant that blocks **T** cell activation via blocking a step in the **IL-2 receptor** signaling pathway

---

# Answer
As opposed to Tacrolimus which blocks IL-2 transcription